Centers

Therapeutic Accelerator Program (TAP)

Drug Discovery Unit

EU-OPENSCREEN

Test

Read more
The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the DDU...
Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Partnerships

Events

Jobs

TB Drug Accelerator

  • The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

 
View all

Evotec and Yale University form Open Innovation Alliance

Evotec and Yale intend to leverage first rate science performed at Yale University together with Evotec's drug discovery infrastructure and expertise into highly innovative discovery approaches in diseases of high unmet medical need. Initially,...

 
View all

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space

Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. Scientists from both groups will be...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All